Australia
Agilent and University of Melbourne Establish Agilent Innovation Hub to Advance Environmental Health Research
Partnership underscores Agilent’s expansion across Asia, including recent establishment of Centres of Excellence within flagship university campuse...
November 13, 2025 | News
Lumonus Raises A$25 Million Series B to Accelerate Global Adoption of Its AI-Powered Oncology Workflow Platform
Lumonus, a leader in AI powered radiation oncology workflow solutions, announced the close of its A$25 million Series B financing round. The roun...
November 10, 2025 | News
PolyActiva and RareSight Forge Strategic Partnership to Develop Sustained-Release Therapies for Rare Pediatric Retinal Diseases
Partnership Leverages PolyActiva’s PREZIA™ Drug Delivery Platform Technology and RareSight’s Expertise in Rare Diseases to Advance Nove...
November 07, 2025 | News
Nuclera Partners with Solve Scientific to Expand Access to eProtein Discovery Across Australia and New Zealand
Partnership with Solve Scientific strengthens international sales as part of ongoing global expansion Nuclera, the biotechnology company acceler...
November 06, 2025 | News
4D Molecular Therapeutics and Otsuka Form $471 Million Partnership to Advance 4D-150 Gene Therapy Across Asia-Pacific
4DMT to receive $85 million upfront cash payment and expect to receive at least $50 million of cost sharing from Otsuka over the next three years for dev...
November 04, 2025 | News
4D Molecular Therapeutics and Otsuka Form $471 Million Partnership to Advance 4D-150 Gene Therapy Across Asia-Pacific
4DMT to receive $85 million upfront cash payment and expect to receive at least $50 million of cost sharing from Otsuka over the next three years for dev...
November 04, 2025 | News
Myrio Therapeutics Partners with University of Pennsylvania and NYU Langone to Advance Next-Generation T Cell Immunotherapies
Myrio Therapeutics, the University of Pennsylvania Perelman School of Medicine, and NYU Langone Health have entered a research collaboration to...
October 29, 2025 | News
Kazia Therapeutics Seeks FDA Guidance on Paxalisib Survival Data in Glioblastoma Under Project FrontRunner Framework
Kazia Therapeutics Limited ("Kazia" or the "Company")announced its intention to request and hold a follow-up Type C meeting with the U.S. Food & Drug A...
October 28, 2025 | News
AdvanCell’s Lead-212 Radioligand Therapy Shows Strong Safety and Efficacy in Phase 1b Trial for Metastatic Prostate Cancer
Results from the TheraPb Phase 1b dose escalation presented at ESMO 2025 show a promising therapeutic index for 212Pb-ADVC001 in patients with metastat...
October 22, 2025 | News
SK Bioscience Files Clinical Trial Application in Australia for GBP511 Universal Coronavirus Vaccine
Candidate designed to protect against COVID-19 variants and broader Sarbecoviruses Phase 1/2 study to enroll ~500 healthy adults, with topline results e...
October 16, 2025 | News
Building Biopharma Resilience: Cytiva’s Joonho Choi on the Power of Connected Ecosystems
Amid global supply chain disruptions, tightening regulations, and shifting patient needs, biopharma resilience has become both a stra...
October 15, 2025 | Interview
South Korean Vaxcellbio Secures Australian Patent for Next-Generation NK Cell Expansion Technology
Vaxcellbio (CEO Je-Jung Lee, MD, PhD ), a biotechnology company specializing in immuno-oncology, announced ,that it has successfully obtained an Aust...
October 14, 2025 | News
Australia’s Cyteph Completes Recruitment for Its First-in-Human Trial of CYT-101 in Glioblastoma
Cyteph Pty Ltd, a biotechnology company developing novel immunotherapies for difficult-to-treat cancers, today announced that it has successfully completed...
October 09, 2025 | News
Anasens Partners with MAVAND Solutions to Expand DrugAsens™ Rapid Oral-Fluid Drug Testing Across Europe and Australia
Anasens Inc., a developer of rapid, connected point-of-care detection tools, announced it has signed a distribution agreement with MAVAND Soluti...
October 08, 2025 | News
Most Read
- Top 25 Biotech & Biopharma Leaders in Sustainable Innovation, 2025
- China’s Biopharma Dealmaking Surges in H1 2025, Driven by Record Licensing and Oncology Focus
- Chikungunya in China: How a “Forgotten” Arbovirus Found the Perfect Storm
- How Innovation Gaps in Biopharma Raise New Safety Concerns
- Smart Implants and the Future of Musculoskeletal Injury Treatment
- How Ethical Gaps in Psychiatry Could Undermine Biopharma Progress
- The Evolving Landscape of Women’s Health Innovation in the Asia-Pacific
- Using NLP-Driven Decision Support in Emergency Health Assistance
- Taiwan Steps Into the Global Spotlight With a New Cancer Therapy
- The Role of Unique Device Identification (UDI) in Tracing Medical Device Safety
- The Importance of a Patient’s Mental Health During Clinical Trials
Bio Jobs
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Avantor’s New CEO Ligner Aims to Unlock Global Potential and Deliver Shareholder Value
- AstraZeneca Commits $50 Billion to U.S. Expansion by 2030 in Biggest-Ever Global Investment
- Thermo Fisher, SAMRC, and South Africa’s Department of Science and Innovation Launch CATIR to Nurture Next-Gen Scientists
- Cube Biotech Appoints Former Sartorius CEO Dr. Joachim Kreuzburg to Board of Directors
- FDA’s AI Transition Marks a Turning Point in Drug Review: Industry Faces Pressure to Adapt Amid 20% Workforce Cut
- WuXi XDC Completes Mechanical Build of Singapore Bioconjugate Manufacturing Hub
News
Editor Picks
